These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15198566)

  • 21. Development of meloxicam in situ implant formulation by quality by design principle.
    Ibrahim HM; Ahmed TA; Hussain MD; Rahman Z; Samy AM; Kaseem AA; Nutan MT
    Drug Dev Ind Pharm; 2014 Jan; 40(1):66-73. PubMed ID: 23298324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Size dependency of PLGA-nanoparticle uptake and antifungal activity against Aspergillus flavus.
    Patel NR; Damann K; Leonardi C; Sabliov CM
    Nanomedicine (Lond); 2011 Oct; 6(8):1381-95. PubMed ID: 21651442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
    Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
    Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-encapsulation of human serum albumin and superparamagnetic iron oxide in PLGA nanoparticles: part I. Effect of process variables on the mean size.
    Shubhra QT; Kardos AF; Feczkó T; Mackova H; Horák D; Tóth J; Dósa G; Gyenis J
    J Microencapsul; 2014; 31(2):147-55. PubMed ID: 23875616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
    He W; Horn SW; Hussain MD
    Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using Box Behnken design.
    Gajra B; Dalwadi C; Patel R
    Daru; 2015 Jan; 23(1):3. PubMed ID: 25604353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery.
    Csaba N; Caamaño P; Sánchez A; Domínguez F; Alonso MJ
    Biomacromolecules; 2005; 6(1):271-8. PubMed ID: 15638530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation, optimization, hemocompatibility and pharmacokinetic evaluation of PLGA nanoparticles containing paclitaxel.
    Mittal P; Vardhan H; Ajmal G; Bonde GV; Kapoor R; Mittal A; Mishra B
    Drug Dev Ind Pharm; 2019 Mar; 45(3):365-378. PubMed ID: 30394795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, fabrication, optimization and characterization of memantine-loaded biodegradable PLGA nanoscaffolds for treatment of Alzheimer's disease.
    Rani V; Chawla R
    Biomed Mater; 2022 Nov; 17(6):. PubMed ID: 36202081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.
    Yang X; Patel S; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2014 Jun; 15(3):569-87. PubMed ID: 24504495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of nanoparticles loaded with benzopsoralen in rat peritoneal exudate cells.
    Gomes AJ; Faustino AS; Lunardi CN; Lunardi LO; Machado AE
    Int J Pharm; 2007 Mar; 332(1-2):153-60. PubMed ID: 17056212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.